HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Electroneuromyography and somatosensory evoked potentials in HTLV-I associated myelopathy].

Abstract
The objective of the present study was to correlate electroneuromyography (ENMG) and evoked potentials findings with clinical aspects and intrathecal synthesis of HTLV-I antibodies production on HTLV-I myelopathy (HAM). Patients were seropositive for HTLV-I by different assays and seronegative for HIV and VDRL. They had no other causes of myelopathy and peripheral neuropathy. Peripheral neuropathy was established in 34.3% of the cases by ENMG. Peripheral neuropathy was mostly asymmetric (82%), sensory motor (90%), axonal (54.5%) or of a mixed type (45.4%). In 63.6% of these cases related symptoms were observed. ABR was abnormal in one patient and the PRVEP in 28.5%, who were symptom-free. The SEP was abnormal in 85.7% of the cases, half of them presenting clinical complaints. In only 14% of the individuals with clinical manifestations, SEP was normal. In 28% of patients with abnormal SEP the ENMG disclosed a peripheral neuropathy.
AuthorsM W Cruz, R B Corrêa, M Puccioni-Sohler, S A Novis
JournalArquivos de neuro-psiquiatria (Arq Neuropsiquiatr) Vol. 56 Issue 4 Pg. 756-62 (Dec 1998) ISSN: 0004-282X [Print] Germany
Vernacular TitleEletroneuromiografia e potenciais evocados somatossensitivos na mielopatia pelo HTLV-I.
PMID10029878 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Albumins
  • Cerebrospinal Fluid Proteins
Topics
  • Adolescent
  • Adult
  • Aged
  • Albumins (analysis)
  • Cerebrospinal Fluid Proteins (analysis)
  • Diagnosis, Differential
  • Electromyography
  • Evoked Potentials, Somatosensory (physiology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Paraparesis, Tropical Spastic (cerebrospinal fluid, diagnosis, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: